knowledge -WSS

knowledge

author：fashion 2025-09-29 19:14:29 - browse：19

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Mark Cuban is blaming the wrong people for high drug costs

Wikipedia

WSS

Medicare proceeds with plan to claw back hospital funds

Montana youths win climate lawsuit against state for promoting fossil fuels

Humans aren't the only ones with an imagination. Rats have it too

The health care issue Democrats can’t solve: hospital reform

How to convince healthy people to buy insurance

Mark Cuban is blaming the wrong people for high drug costs

hotspot

knowledge

explore

Peter Hotez and the public health issue of online harassment

Kidney transplant patients stopped immunosuppressants in trial

Tori Bowie and the unacceptable rates of Black maternal death

Inari Medical to buy amputation prevention company LimFlow

Moonlake's readout produced a cash windfall. Risks remain

Senators push IRS to launch nonprofit hospital probe

The high cost of giving birth even with insurance

Illumina slashes 2023 revenue projections yet again

Alkermes shareholders re

Inari Medical to buy amputation prevention company LimFlow

explore

Montana youths win climate lawsuit against state for promoting fossil fuels

Explaining an after

Bird flu researchers hone in on Finland’s mink farms

Key Senate panel to consider PBM, drug pricing reform package

Infant mortality in U.S. rose last year for first time in decades: CDC

After Optum profits sink, UnitedHealth makes changes

focus

Wikipedia

explore

explore